Recent Finacing
Recent Raise
Protara is a clinical-stage biotech developing TARA-002, a cell-based therapy in Phase 2 trials for non-muscle invasive bladder cancer and pediatric lymphatic malformations, plus IV choline chloride for parenteral nutrition.